Two contracts supplied 100% of York Space Systems' gross unfavorable estimate-at-completion adjustments in the latest filing. The company attributed those costs mainly to extra labor, materials, and subcontractor work.
That is the small operational detail inside a much larger split-screen: York's revenue fell 20.5% to $92.5 million over the six months ended June 30, while gross profit barely changed at $22.2 million. Gross margin consequently rose to 24.0% from 19.0%. Sales shrank; the dollars left after production did not.
The contract table shows that the improvement did not eliminate execution costs. York recorded $1.029 million of gross unfavorable EAC adjustments, down sharply from $13.461 million in the comparable period, but two contracts still accounted for 64% and 36% of that current-period amount.
"The table below presents the aggregate amounts for the following periods: For the three months ended June 30, ($ in thousands) 2026 2025 Gross favorable EAC adjustments $ 207 $ 11 Gross unfavorable EAC adjustments (1,029) (13,461) EAC adjustments, attributable to loss contracts 383 (362) Net EAC adjustments, before income taxes $ (439) $ (13,812) Net EAC adjustments, net of income taxes $ (442) $ (12,429) Two contracts accounted for 64% and 36% respectively, of the gross unfavorable EAC adjustment for the three months ended June 30, 2026 which were primarily due to additional unplanned labor, materials and subcontractor costs."
10-Q 2026-08-14
In plain English, the contract-loss drag was much smaller than a year earlier, but it remained concentrated and tied to work that cost more than planned. That helps explain why operating income improved from a $110.5 million loss to a $41.3 million loss, without turning the business profitable.
Cash is the less forgiving line. Operating cash flow was a $186.6 million outflow, more than twice the comparable $84.5 million outflow. Inventory rose 22.2% to $41.8 million, and capital spending increased 59.7% to $3.4 million. The 10-Q does not give a single cause for the cash-flow deterioration.
The balance sheet also carries a financing footnote in large type. York ended the period with $534.0 million of cash, down from $655.7 million, even after raising $589.6 million through its IPO. Financing supplied $587.8 million of net cash, while investing used $29.7 million, primarily for the Orbion and Solestial acquisitions.
"Net cash provided by financing activities was $587.8 million for the six months ended June 30, 2026, as compared to $25.0 million for the six months ended June 30, 2025, primarily due to proceeds from issuance of the Company's common stock in connection with the IPO, net of underwriting discounts and commissions and other offering costs, of $589.6 million."
10-Q 2026-08-14
The takeaway is not that York's reported losses vanished. It is that the income statement and cash account are moving on different tracks: margins improved while contract adjustments eased, while the business consumed more cash and financing included newly issued stock.
York's shares closed at $10.93 on August 14, down 5.0% that day. The next useful disclosure is not another headline loss number, but the company's explanation of why revenue fell while gross profit held nearly flat.
The 10-Q leaves one question open: why did revenue fall 20.5% while gross profit held at $22.2 million?